loobobilly News: Federal Supply Deal For COVID-19 Antibody Treatment Lacks Some Customary Protections

Federal Supply Deal For COVID-19 Antibody Treatment Lacks Some Customary Protections To boost the supply of Regeneron's antibody therapy for COVID-19, the federal government entered into a $450 million supply contract. Details of the deal show some safeguards are missing. To boost the supply of Regeneron's antibody therapy for COVID-19, the federal government entered into a $450 million supply contract. Details of the deal show some safeguards are missing. Business
To boost the supply of Regeneron's antibody therapy for COVID-19, the federal government entered into a $450 million supply contract. Details of the deal show some safeguards are missing.

Read more on NPR